Operating Income for Boston Scientific (BSX)
According to Boston Scientific's latest reported financial statements, the company's current operating income (TTM) is $4.15B USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingOperating IncomeSwitch metric
TTM (last 4 quarters)
$4.15B
YoY change
+50.7%
5Y CAGR
+45.9%
Peak year (2025)
$3.97B
Cumulative operating income
$37.88B
Operating Income history chart for Boston Scientific (BSX) from 1991 to 2025
Operating Income history table for Boston Scientific (BSX) from 1991 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY |
|---|---|---|---|---|
| 2025 | $3.97B | +50.7% | ||
| 2024 | $2.63B | +20.8% | ||
| 2023 | $2.18B | +19.6% | ||
| 2022 | $1.82B | -5.1% | ||
| 2021 | $1.92B | +219.8% | ||
| 2020 | $601.00M | -64.9% | ||
| 2019 | $1.71B | -1.4% | ||
| 2018 | $1.74B | +13.9% | ||
| 2017 | $1.52B | +23.4% | ||
| 2016 | $1.24B | +56.5% | ||
| 2015 | $790.00M | -6.5% | ||
| 2014 | $845.00M | -3.0% | ||
| 2013 | $871.00M | -12.4% | ||
| 2012 | $994.00M | -11.5% | ||
| 2011 | $1.12B | +4.7% | ||
| 2010 | $1.07B | -17.7% | ||
| 2009 | $1.30B | +0.6% | ||
| 2008 | $1.29B | +9.7% | ||
| 2007 | $1.18B | -4.5% | ||
| 2006 | $1.24B | -39.0% | ||
| 2005 | $2.02B | +14.3% | ||
| 2004 | $1.77B | +154.1% | ||
| 2003 | $697.00M | +14.3% | ||
| 2002 | $610.00M | +510.0% | ||
| 2001 | $100.00M | -85.2% | ||
| 2000 | $675.00M | -6.9% | ||
| 1999 | $725.00M | -426.0% | ||
| 1998 | -$222.40M | -153.6% | ||
| 1997 | $414.80M | +21.4% | ||
| 1996 | $341.80M | +19.9% | ||
| 1995 | $285.00M | +119.2% | ||
| 1994 | $130.00M | +19.7% | ||
| 1993 | $108.60M | +17.0% | ||
| 1992 | $92.80M | +31.6% | ||
| 1991 | $70.50M | — |
Operating Income values are taken from Boston Scientific's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Boston Scientific (BSX) operating income totalled $3.97B – surged 50.7% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Boston Scientific operating income compounded at +45.9% per year, sustaining 3 straight years of year-over-year growth.
2025 marks the peak operating income at $3.97B, with the historical low of -$222.40M recorded in 1998.
Among 8 Healthcare peers, Boston Scientific (BSX) ranks 9th; the peer median for operating income is $22.84B.
Boston Scientific Operating Income by Year
Boston Scientific Operating Income 2025: $3.97B
Boston Scientific operating income in 2025 was $3.97B, surged 50.7% from 2024. This figure represents the highest annual value in the available history.
Boston Scientific Operating Income 2024: $2.63B
Boston Scientific operating income in 2024 was $2.63B, grew 20.8% from 2023.
Boston Scientific Operating Income 2023: $2.18B
Boston Scientific operating income in 2023 was $2.18B, grew 19.6% from 2022.
Boston Scientific Operating Income 2022: $1.82B
Boston Scientific operating income in 2022 was $1.82B, declined 5.1% below 2021.
Boston Scientific Operating Income 2021: $1.92B
Boston Scientific operating income in 2021 was $1.92B.
See more financial history for Boston Scientific (BSX).
Sector peers — Operating Income
Companies in the same sector as Boston Scientific, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $127.66B | Healthcare |
| Eli Lilly and Company (LLY) | $29.70B | Healthcare |
| Merck & Co., Inc. (MRK) | $26.78B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| AbbVie Inc. (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $18.96B | Healthcare |
| AstraZeneca PLC (AZN) | $13.74B | Healthcare |
| Amgen Inc. (AMGN) | $10.68B | Healthcare |
Frequently asked questions
What is Boston Scientific's operating income?
- Latest reported operating income for Boston Scientific (BSX) is $4.15B (period ending March 31, 2026).
How has Boston Scientific operating income changed year-over-year?
- Boston Scientific (BSX) operating income changed +50.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Boston Scientific operating income?
- Boston Scientific (BSX) operating income compound annual growth rate is +45.9% over the most recent 5 years available.
When did Boston Scientific operating income hit its highest annual value?
- Boston Scientific operating income reached its highest annual value of $3.97B in 2025.
What was Boston Scientific operating income in 2024?
- Boston Scientific (BSX) operating income in 2024 was $2.63B.
What was Boston Scientific operating income in 2025?
- Boston Scientific (BSX) operating income in 2025 was $3.97B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BSX Overview
Company profile, financial tools, and key metrics
BSX Revenue Counter
Earns $653.70 every second. See per minute, hour, and day.
BSX Earnings Counter
Earns $112.66 per second net profit. See per minute, hour, and day.
BSX Economic Scale
Exceeds Niger's GDP. Compare with world economies.
BSX What If Invested
What if you had invested $1,000? See historical returns from any date.
BSX How It Makes Money
Discover visual breakdown of $20.61B in revenue — where it comes from and where it goes.
BSX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BSX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BSX Daily Price Character
Balanced · 48.8% historical win rate (green days). Streaks & record days.
BSX Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BSX Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.